From: Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria
Pf all (n = 267) | Median (IQR) | Pf 3D7 (n = 254) Median (IQR) | Pf K13 (n = 15) Median (IQR) | P. vivax (n = 46) Median (IQR) | P-value (3D7 vs K13) d | P-value (Pf all vs P. vivax) d | |
---|---|---|---|---|---|---|---|
Baseline RCC (× 1012/L) | 5.0 (4.7–5.8) | 5.0 (4.7–5.8) | 5.1 (4.6–5.2) | 5.0 (4.7–5.2) | 0.58 | 0.57 | |
Nadir RCC (× 1012/L) | 4.5 (4.2–4.8) | 4.5 (4.2–4.8) | 4.4 (3.8–4.6) | 4.4 (4.0–4.8) | 0.07 | 0.31 | |
Total RCC Loss (× 1012/L) | 0.5 (0.3–0.7) | 0.5 (0.3–0.6) | 0.7 (0.6–0.8) | 0.5 (0.4–0.6) | 0.0005 | 0.57 | |
Malaria-attributable RCC loss (× 1012/L) a | 0.21 (0.04–0.36) | 0.20 (0.04–0.33) | 0.34 (0.12–0.50) | 0.21 (0.04–0.33) | 0.06 | 0.87 | |
Malaria-attributable RCC loss/total RCC loss (%) b | 42 (13–51) | 40 (13–55) | 49 (20–63) | 42 (13–55) | 0.29 | 0.46 | |
Loss of pRBC/total malaria-attributable RBC loss (%) c | 0.015 (0.006–0.060) | 0.014 (0.005–0.039) | 0.128 (0.068–0.616) | 0.022 (0.008–0.082) |  < 0.0001 | 0.19 |